{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:05:38Z","timestamp":1792663538075,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFA1302704"],"award-info":[{"award-number":["2022YFA1302704"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58795-2","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T17:57:13Z","timestamp":1744912633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["An oncohistone-driven H3.3K27M\/CREB5\/ID1 axis maintains the stemness and malignancy of diffuse intrinsic pontine glioma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3676-0793","authenticated-orcid":false,"given":"Wei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2504-1883","authenticated-orcid":false,"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-9220","authenticated-orcid":false,"given":"Changcun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9980-9662","authenticated-orcid":false,"given":"Luyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-5780","authenticated-orcid":false,"given":"Yujie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-3765","authenticated-orcid":false,"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-4131","authenticated-orcid":false,"given":"Qiaoran","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"58795_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrc3811","volume":"14","author":"C Jones","year":"2014","unstructured":"Jones, C. & Baker, S. J. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat. Rev. Cancer 14, 651\u2013661 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"58795_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay, A. et al. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer Cell 32, 520\u2013537.e525 (2017).","journal-title":"Cancer Cell"},{"key":"58795_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1158\/2159-8290.CD-12-0426","volume":"3","author":"L Bjerke","year":"2013","unstructured":"Bjerke, L. et al. Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN. Cancer Discov. 3, 512\u2013519 (2013).","journal-title":"Cancer Discov."},{"key":"58795_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccell.2019.09.005","volume":"36","author":"JN Anastas","year":"2019","unstructured":"Anastas, J. N. et al. Re-programing Chromatin with a Bifunctional LSD1\/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell 36, 528\u2013544.e510 (2019).","journal-title":"Cancer Cell"},{"key":"58795_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-020-00218-w","volume":"7","author":"D Srikanthan","year":"2021","unstructured":"Srikanthan, D. et al. Diffuse intrinsic pontine glioma: current insights and future directions. Chin. Neurosurg. J. 7, 6 (2021).","journal-title":"Chin. Neurosurg. J."},{"key":"58795_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet 44, 251\u2013253 (2012).","journal-title":"Nat. Genet"},{"key":"58795_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226\u2013231 (2012).","journal-title":"Nature"},{"key":"58795_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis, P. W. et al. Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma. Science 340, 857\u2013861 (2013).","journal-title":"Science"},{"key":"58795_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1101\/gad.217778.113","volume":"27","author":"K-M Chan","year":"2013","unstructured":"Chan, K.-M. et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev. 27, 985\u2013990 (2013).","journal-title":"Genes Dev."},{"key":"58795_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender, S. et al. Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas. Cancer Cell 24, 660\u2013672 (2013).","journal-title":"Cancer Cell"},{"key":"58795_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09140-x","volume":"10","author":"AS Harutyunyan","year":"2019","unstructured":"Harutyunyan, A. S. et al. H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2\/me3 and is essential for glioma tumorigenesis. Nat. Commun. 10, 1262 (2019).","journal-title":"Nat. Commun."},{"key":"58795_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.molcel.2020.09.028","volume":"80","author":"SU Jain","year":"2020","unstructured":"Jain, S. U. et al. H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2. Mol. Cell 80, 726\u2013735.e727 (2020).","journal-title":"Mol. Cell"},{"key":"58795_CR13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.molcel.2018.05.023","volume":"70","author":"O Oksuz","year":"2018","unstructured":"Oksuz, O. et al. Capturing the Onset of PRC2-Mediated Repressive Domain Formation. Mol. Cell 70, 1149\u20131162.e1145 (2018).","journal-title":"Mol. Cell"},{"key":"58795_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201883119","volume":"119","author":"K Kraft","year":"2022","unstructured":"Kraft, K. et al. Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation. Proc. Natl Acad. Sci. USA 119, e2201883119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58795_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.ccell.2019.04.004","volume":"35","author":"B Krug","year":"2019","unstructured":"Krug, B. et al. Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas. Cancer Cell 35, 782\u2013797.e788 (2019).","journal-title":"Cancer Cell"},{"key":"58795_CR16","doi-asserted-by":"crossref","unstructured":"Harutyunyan, A. S. et al. H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation. Cell Rep. 33, 108390 (2020).","DOI":"10.1016\/j.celrep.2020.108390"},{"key":"58795_CR17","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41588-022-01205-w","volume":"54","author":"S Jessa","year":"2022","unstructured":"Jessa, S. et al. K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas. Nat. Genet. 54, 1865\u20131880 (2022).","journal-title":"Nat. Genet."},{"key":"58795_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.trecan.2023.02.003","volume":"9","author":"AF Andrade","year":"2023","unstructured":"Andrade, A. F., Chen, C. C. L. & Jabado, N. Oncohistones in brain tumors: the soil and seed. Trends Cancer 9, 444\u2013455 (2023).","journal-title":"Trends Cancer"},{"key":"58795_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","volume":"23","author":"A Piunti","year":"2017","unstructured":"Piunti, A. et al. Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat. Med. 23, 493\u2013500 (2017).","journal-title":"Nat. Med."},{"key":"58795_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","volume":"22","author":"A Piunti","year":"2021","unstructured":"Piunti, A. & Shilatifard, A. The roles of Polycomb repressive complexes in mammalian development and cancer. Nat. Rev. Mol. Cell Biol. 22, 326\u2013345 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58795_CR21","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1101\/gad.309013.117","volume":"31","author":"F Mohammad","year":"2017","unstructured":"Mohammad, F. & Helin, K. Oncohistones: drivers of pediatric cancers. Genes Dev. 31, 2313\u20132324 (2017).","journal-title":"Genes Dev."},{"key":"58795_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"F Mohammad","year":"2017","unstructured":"Mohammad, F. et al. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat. Med. 23, 483\u2013492 (2017).","journal-title":"Nat. Med."},{"key":"58795_CR23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","volume":"76","author":"S Nagaraja","year":"2019","unstructured":"Nagaraja, S. et al. Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State. Mol. Cell 76, 965\u2013980.e912 (2019).","journal-title":"Mol. Cell"},{"key":"58795_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg4126","volume":"7","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Epigenomic landscape and 3D genome structure in pediatric high-grade glioma. Sci. Adv. 7, eabg4126 (2021).","journal-title":"Sci. Adv."},{"key":"58795_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"MG Filbin","year":"2018","unstructured":"Filbin, M. G. et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360, 331\u2013335 (2018).","journal-title":"Science"},{"key":"58795_CR26","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41588-019-0531-7","volume":"51","author":"S Jessa","year":"2019","unstructured":"Jessa, S. et al. Stalled developmental programs at the root of pediatric brain tumors. Nat. Genet. 51, 1702\u20131713 (2019).","journal-title":"Nat. Genet."},{"key":"58795_CR27","first-page":"2880","volume":"12","author":"E Panditharatna","year":"2022","unstructured":"Panditharatna, E. et al. BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma. Cancer Discov. 12, 2880\u20132905 (2022).","journal-title":"Cancer Discov."},{"key":"58795_CR28","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/S0021-9258(18)53604-8","volume":"268","author":"N Nomura","year":"1993","unstructured":"Nomura, N. et al. Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1. J. Biol. Chem. 268, 4259\u20134266 (1993).","journal-title":"J. Biol. Chem."},{"key":"58795_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13046-020-01673-0","volume":"39","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET. J. Exp. Clin. Cancer Res. 39, 168 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"58795_CR30","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.celrep.2019.10.068","volume":"29","author":"JH Hwang","year":"2019","unstructured":"Hwang, J. H. et al. CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer. Cell Rep. 29, 2355\u20132370.e2356 (2019).","journal-title":"Cell Rep."},{"key":"58795_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35010-0","volume":"13","author":"C-H Zhang","year":"2022","unstructured":"Zhang, C.-H. et al. Creb5 coordinates synovial joint formation with the genesis of articular cartilage. Nat. Commun. 13, 7295 (2022).","journal-title":"Nat. Commun."},{"key":"58795_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80405","volume":"11","author":"J Feng","year":"2022","unstructured":"Feng, J. et al. TGF-\u03b2 signaling and Creb5 cooperatively regulate Fgf18 to control pharyngeal muscle development. eLife 11, e80405 (2022).","journal-title":"eLife"},{"key":"58795_CR33","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/s41385-022-00556-1","volume":"15","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Single-cell RNA transcriptomic analysis identifies Creb5 and CD11b-DCs as regulator of asthma exacerbations. Mucosal Immunol. 15, 1363\u20131374 (2022).","journal-title":"Mucosal Immunol."},{"key":"58795_CR34","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1016\/j.neuron.2023.06.013","volume":"111","author":"A Kumar","year":"2023","unstructured":"Kumar, A. et al. 2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer\u2019s resilience. Neuron 111, 2831\u20132846.e2810 (2023).","journal-title":"Neuron"},{"key":"58795_CR35","doi-asserted-by":"publisher","first-page":"1122647","DOI":"10.3389\/fnagi.2023.1122647","volume":"15","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson\u2019s disease. Front Aging Neurosci. 15, 1122647 (2023).","journal-title":"Front Aging Neurosci."},{"key":"58795_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73223","volume":"11","author":"JH Hwang","year":"2022","unstructured":"Hwang, J. H. et al. CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies. eLife 11, e73223 (2022).","journal-title":"eLife"},{"key":"58795_CR37","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1158\/0008-5472.CAN-18-1357","volume":"79","author":"R Sachdeva","year":"2019","unstructured":"Sachdeva, R. et al. ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma. Cancer Res 79, 4057 (2019).","journal-title":"Cancer Res"},{"key":"58795_CR38","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.celrep.2016.06.092","volume":"16","author":"X Jin","year":"2016","unstructured":"Jin, X. et al. The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells. Cell Rep. 16, 1629\u20131641 (2016).","journal-title":"Cell Rep."},{"key":"58795_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccr.2010.10.023","volume":"18","author":"J Anido","year":"2010","unstructured":"Anido, J. et al. TGF-\u03b2 Receptor Inhibitors Target the CD44high\/Id1high Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell 18, 655\u2013668 (2010).","journal-title":"Cancer Cell"},{"key":"58795_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrc3638","volume":"14","author":"A Lasorella","year":"2014","unstructured":"Lasorella, A., Benezra, R. & Iavarone, A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat. Rev. Cancer 14, 77\u201391 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"58795_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0092-8674(90)90214-Y","volume":"61","author":"R Benezra","year":"1990","unstructured":"Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. & Weintraub, H. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49\u201359 (1990).","journal-title":"Cell"},{"key":"58795_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1158\/2159-8290.CD-19-0529","volume":"10","author":"Y-H Huang","year":"2020","unstructured":"Huang, Y.-H. et al. ID1 Mediates Escape from TGF\u03b2 Tumor Suppression in Pancreatic Cancer. Cancer Discov. 10, 142\u2013157 (2020).","journal-title":"Cancer Discov."},{"key":"58795_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrc1673","volume":"5","author":"J Perk","year":"2005","unstructured":"Perk, J., Iavarone, A. & Benezra, R. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603\u2013614 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"58795_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1128\/MCB.20.2.429-440.2000","volume":"20","author":"ME Massari","year":"2000","unstructured":"Massari, M. E. & Murre, C. Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms. Mol. Cell. Biol. 20, 429\u2013440 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"58795_CR45","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1074\/jbc.M111023200","volume":"277","author":"O Korchynskyi","year":"2002","unstructured":"Korchynskyi, O. & ten Dijke, P. Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*. J. Biol. Chem. 277, 4883\u20134891 (2002).","journal-title":"J. Biol. Chem."},{"key":"58795_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor, K. R. et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat. Genet. 46, 457\u2013461 (2014).","journal-title":"Nat. Genet."},{"key":"58795_CR47","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso, A. M. et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat. Genet. 46, 462\u2013466 (2014).","journal-title":"Nat. Genet."},{"key":"58795_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz, P. et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat. Genet 46, 451\u2013456 (2014).","journal-title":"Nat. Genet"},{"key":"58795_CR49","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ccell.2020.02.002","volume":"37","author":"J Fortin","year":"2020","unstructured":"Fortin, J. et al. Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas. Cancer Cell 37, 308\u2013323.e312 (2020).","journal-title":"Cancer Cell"},{"key":"58795_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08823-9","volume":"10","author":"CM Hoeman","year":"2019","unstructured":"Hoeman, C. M. et al. ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nat. Commun. 10, 1023 (2019).","journal-title":"Nat. Commun."},{"key":"58795_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s42003-019-0420-8","volume":"2","author":"D Carvalho","year":"2019","unstructured":"Carvalho, D. et al. ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma. Commun. Biol. 2, 156 (2019).","journal-title":"Commun. Biol."},{"key":"58795_CR52","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s43018-022-00408-8","volume":"3","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. Context-dependent tumor-suppressive BMP signaling in diffuse intrinsic pontine glioma regulates stemness through epigenetic regulation of CXXC5. Nat. Cancer 3, 1105\u20131122 (2022).","journal-title":"Nat. Cancer"},{"key":"58795_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/neuonc\/noac141","volume":"25","author":"D Messinger","year":"2023","unstructured":"Messinger, D. et al. Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma. Neuro Oncol. 25, 54\u201367 (2023).","journal-title":"Neuro Oncol."},{"key":"58795_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2019.04.043","volume":"43","author":"Y Sun","year":"2019","unstructured":"Sun, Y. et al. Potent anti-tumor efficacy of palbociclib in treatment-na\u00efve H3.3K27M-mutant diffuse intrinsic pontine glioma. EBioMedicine 43, 171\u2013179 (2019).","journal-title":"EBioMedicine"},{"key":"58795_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja, S. et al. Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. Cancer Cell 31, 635\u2013652.e636 (2017).","journal-title":"Cancer Cell"},{"key":"58795_CR56","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"58795_CR57","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande, B. et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15, 2247\u20132276 (2020).","journal-title":"Nat. Protoc."},{"key":"58795_CR58","doi-asserted-by":"publisher","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","volume":"7","author":"S Puget","year":"2012","unstructured":"Puget, S. et al. Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 7, e30313 (2012).","journal-title":"PLoS One"},{"key":"58795_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16682-y","volume":"11","author":"LH Chen","year":"2020","unstructured":"Chen, L. H. et al. The integrated genomic and epigenomic landscape of brainstem glioma. Nat. Commun. 11, 3077 (2020).","journal-title":"Nat. Commun."},{"key":"58795_CR60","doi-asserted-by":"publisher","first-page":"e0193565","DOI":"10.1371\/journal.pone.0193565","volume":"13","author":"NE Berlow","year":"2018","unstructured":"Berlow, N. E. et al. IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma. PLoS One 13, e0193565 (2018).","journal-title":"PLoS One"},{"key":"58795_CR61","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1253799","volume":"346","author":"K Funato","year":"2014","unstructured":"Funato, K., Major, T., Lewis, P. W., Allis, C. D. & Tabar, V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346, 1529\u20131533 (2014).","journal-title":"Science"},{"key":"58795_CR62","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","volume":"35","author":"JD Larson","year":"2019","unstructured":"Larson, J. D. et al. Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression. Cancer Cell 35, 140\u2013155.e147 (2019).","journal-title":"Cancer Cell"},{"key":"58795_CR63","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s41588-021-00897-w","volume":"53","author":"GL Brien","year":"2021","unstructured":"Brien, G. L. et al. Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells. Nat. Genet. 53, 1221\u20131232 (2021).","journal-title":"Nat. Genet."},{"key":"58795_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"I Dunham","year":"2012","unstructured":"Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"58795_CR65","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41593-020-00794-1","volume":"24","author":"UC Eze","year":"2021","unstructured":"Eze, U. C., Bhaduri, A., Haeussler, M., Nowakowski, T. J. & Kriegstein, A. R. Single-cell atlas of early human brain development highlights heterogeneity of human neuroepithelial cells and early radial glia. Nat. Neurosci. 24, 584\u2013594 (2021).","journal-title":"Nat. Neurosci."},{"key":"58795_CR66","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-021-03910-8","volume":"598","author":"A Bhaduri","year":"2021","unstructured":"Bhaduri, A. et al. An atlas of cortical arealization identifies dynamic molecular signatures. Nature 598, 200\u2013204 (2021).","journal-title":"Nature"},{"key":"58795_CR67","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.stem.2019.03.006","volume":"24","author":"Q Weng","year":"2019","unstructured":"Weng, Q. et al. Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis. Cell Stem Cell 24, 707\u2013723.e708 (2019).","journal-title":"Cell Stem Cell"},{"key":"58795_CR68","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41592-023-01884-1","volume":"20","author":"F Jiang","year":"2023","unstructured":"Jiang, F. et al. Simultaneous profiling of spatial gene expression and chromatin accessibility during mouse brain development. Nat. Methods 20, 1048\u20131057 (2023).","journal-title":"Nat. Methods"},{"key":"58795_CR69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.neuron.2007.04.019","volume":"54","author":"FD Miller","year":"2007","unstructured":"Miller, F. D. & Gauthier, A. S. Timing Is Everything: Making Neurons versus Glia in the Developing Cortex. Neuron 54, 357\u2013369 (2007).","journal-title":"Neuron"},{"key":"58795_CR70","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-021-03775-x","volume":"596","author":"G La Manno","year":"2021","unstructured":"La Manno, G. et al. Molecular architecture of the developing mouse brain. Nature 596, 92\u201396 (2021).","journal-title":"Nature"},{"key":"58795_CR71","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1073\/pnas.0601492103","volume":"103","author":"AP Lee","year":"2006","unstructured":"Lee, A. P., Koh, E. G. L., Tay, A., Brenner, S. & Venkatesh, B. Highly conserved syntenic blocks at the vertebrate Hox loci and conserved regulatory elements within and outside Hox gene clusters. Proc. Natl Acad. Sci. 103, 6994\u20136999 (2006).","journal-title":"Proc. Natl Acad. Sci."},{"key":"58795_CR72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1525-142X.2004.04050.x","volume":"6","author":"JA Lehoczky","year":"2004","unstructured":"Lehoczky, J. A., Williams, M. E. & Innis, J. W. Conserved expression domains for genes upstream and within the HoxA and HoxD clusters suggests a long-range enhancer existed before cluster duplication. Evol. Dev. 6, 423\u2013430 (2004).","journal-title":"Evol. Dev."},{"key":"58795_CR73","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1073\/pnas.1504783112","volume":"112","author":"M Vieux-Rochas","year":"2015","unstructured":"Vieux-Rochas, M., Fabre, P. J., Leleu, M., Duboule, D. & Noordermeer, D. Clustering of mammalian Hox genes with other H3K27me3 targets within an active nuclear domain. Proc. Natl Acad. Sci. USA 112, 4672\u20134677 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58795_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.molcel.2018.05.032","volume":"71","author":"Y Ogiyama","year":"2018","unstructured":"Ogiyama, Y., Schuettengruber, B., Papadopoulos, G. L., Chang, J. M. & Cavalli, G. Polycomb-Dependent Chromatin Looping Contributes to Gene Silencing during Drosophila Development. Mol. Cell 71, 73\u201388.e75 (2018).","journal-title":"Mol. Cell"},{"key":"58795_CR75","doi-asserted-by":"publisher","first-page":"8764","DOI":"10.1073\/pnas.1701291114","volume":"114","author":"KP Eagen","year":"2017","unstructured":"Eagen, K. P., Aiden, E. L. & Kornberg, R. D. Polycomb-mediated chromatin loops revealed by a subkilobase-resolution chromatin interaction map. Proc. Natl Acad. Sci. USA 114, 8764\u20138769 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58795_CR76","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.devcel.2019.05.021","volume":"50","author":"C Gentile","year":"2019","unstructured":"Gentile, C. et al. PRC2-Associated Chromatin Contacts in the Developing Limb Reveal a Possible Mechanism for the Atypical Role of PRC2 in HoxA Gene Expression. Dev. Cell 50, 184\u2013196.e184 (2019).","journal-title":"Dev. Cell"},{"key":"58795_CR77","doi-asserted-by":"crossref","unstructured":"Liang, Z. et al. PICKLE-mediated nucleosome condensing drives H3K27me3 spreading for the inheritance of Polycomb memory during differentiation. Mol. Cell 84, 3438\u20133454.e3438 (2024).","DOI":"10.1016\/j.molcel.2024.08.018"},{"key":"58795_CR78","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/ncb1787","volume":"10","author":"KH Hansen","year":"2008","unstructured":"Hansen, K. H. et al. A model for transmission of the H3K27me3 epigenetic mark. Nat. Cell Biol. 10, 1291\u20131300 (2008).","journal-title":"Nat. Cell Biol."},{"key":"58795_CR79","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature08398","volume":"461","author":"R Margueron","year":"2009","unstructured":"Margueron, R. et al. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 461, 762\u2013767 (2009).","journal-title":"Nature"},{"key":"58795_CR80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41594-018-0023-y","volume":"25","author":"S Poepsel","year":"2018","unstructured":"Poepsel, S., Kasinath, V. & Nogales, E. Cryo-EM structures of PRC2 simultaneously engaged with two functionally distinct nucleosomes. Nat. Struct. Mol. Biol. 25, 154\u2013162 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"58795_CR81","doi-asserted-by":"publisher","first-page":"eaau9739","DOI":"10.1126\/sciadv.aau9739","volume":"5","author":"S De","year":"2019","unstructured":"De, S., Cheng, Y., Sun, M.-a, Gehred, N. D. & Kassis, J. A. Structure and function of an ectopic Polycomb chromatin domain. Sci. Adv. 5, eaau9739 (2019).","journal-title":"Sci. Adv."},{"key":"58795_CR82","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41580-021-00398-y","volume":"22","author":"NP Blackledge","year":"2021","unstructured":"Blackledge, N. P. & Klose, R. J. The molecular principles of gene regulation by Polycomb repressive complexes. Nat. Rev. Mol. Cell Biol. 22, 815\u2013833 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58795_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110836","volume":"39","author":"N Furth","year":"2022","unstructured":"Furth, N. et al. H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape. Cell Rep. 39, 110836 (2022).","journal-title":"Cell Rep."},{"key":"58795_CR84","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41580-022-00464-z","volume":"23","author":"A Balsalobre","year":"2022","unstructured":"Balsalobre, A. & Drouin, J. Pioneer factors as master regulators of the epigenome and cell fate. Nat. Rev. Mol. Cell Biol. 23, 449\u2013464 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58795_CR85","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s43018-020-00135-y","volume":"2","author":"AC Watt","year":"2021","unstructured":"Watt, A. C. et al. CDK4\/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity. Nat. Cancer 2, 34\u201348 (2021).","journal-title":"Nat. Cancer"},{"key":"58795_CR86","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent, L. N. & Leone, G. The broken cycle: E2F dysfunction in cancer. Nat. Rev. Cancer 19, 326\u2013338 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"58795_CR87","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1158\/2159-8290.CD-21-1492","volume":"12","author":"Y Mo","year":"2022","unstructured":"Mo, Y. et al. Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4. Cancer Discov. 12, 2906\u20132929 (2022).","journal-title":"Cancer Discov."},{"key":"58795_CR88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41421-021-00262-5","volume":"7","author":"Z He","year":"2021","unstructured":"He, Z., Chen, K., Ye, Y. & Chen, Z. Structure of the SWI\/SNF complex bound to the nucleosome and insights into the functional modularity. Cell Discov. 7, 28 (2021).","journal-title":"Cell Discov."},{"key":"58795_CR89","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n, J. et al. Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"58795_CR90","doi-asserted-by":"publisher","first-page":"8369","DOI":"10.1021\/acs.jmedchem.7b00746","volume":"60","author":"KF McDaniel","year":"2017","unstructured":"McDaniel, K. F. et al. Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075\/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor. J. Med. Chem. 60, 8369\u20138384 (2017).","journal-title":"J. Med. Chem."},{"key":"58795_CR91","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","volume":"578","author":"EJ Faivre","year":"2020","unstructured":"Faivre, E. J. et al. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer. Nature 578, 306\u2013310 (2020).","journal-title":"Nature"},{"key":"58795_CR92","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/nm1111-1325","volume":"17","author":"MW Moyer","year":"2011","unstructured":"Moyer, M. W. First drugs found to inhibit elusive cancer target. Nat. Med. 17, 1325 (2011).","journal-title":"Nat. Med."},{"key":"58795_CR93","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524\u2013528 (2011).","journal-title":"Nature"},{"key":"58795_CR94","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/nn.4095","volume":"18","author":"E Korb","year":"2015","unstructured":"Korb, E., Herre, M., Zucker-Scharff, I., Darnell, R. B. & Allis, C. D. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice. Nat. Neurosci. 18, 1464\u20131473 (2015).","journal-title":"Nat. Neurosci."},{"key":"58795_CR95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221175120","volume":"120","author":"M Mota","year":"2023","unstructured":"Mota, M. et al. Targeting SWI\/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas. Proc. Natl Acad. Sci. 120, e2221175120 (2023).","journal-title":"Proc. Natl Acad. Sci."},{"key":"58795_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou, T.-C. & Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzym. Regul. 22, 27\u201355 (1984).","journal-title":"Adv. Enzym. Regul."},{"key":"58795_CR97","doi-asserted-by":"publisher","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","volume":"48","author":"A Ianevski","year":"2020","unstructured":"Ianevski, A., Giri, A. K. & Aittokallio, T. SynergyFinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 48, W488\u2013W493 (2020).","journal-title":"Nucleic Acids Res."},{"key":"58795_CR98","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nsmb.2461","volume":"20","author":"RJ Burgess","year":"2013","unstructured":"Burgess, R. J. & Zhang, Z. Histone chaperones in nucleosome assembly and human disease. Nat. Struct. Mol. Biol. 20, 14\u201322 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"58795_CR99","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrm2861","volume":"11","author":"PB Talbert","year":"2010","unstructured":"Talbert, P. B. & Henikoff, S. Histone variants \u2014 ancient wrap artists of the epigenome. Nat. Rev. Mol. Cell Biol. 11, 264\u2013275 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58795_CR100","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.trecan.2019.10.009","volume":"5","author":"X Zhang","year":"2019","unstructured":"Zhang, X. & Zhang, Z. Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma. Trends Cancer 5, 799\u2013808 (2019).","journal-title":"Trends Cancer"},{"key":"58795_CR101","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cell.2013.02.014","volume":"152","author":"TI Lee","year":"2013","unstructured":"Lee, T. I. & Young, R. A. Transcriptional regulation and its misregulation in disease. Cell 152, 1237\u20131251 (2013).","journal-title":"Cell"},{"key":"58795_CR102","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrc906","volume":"2","author":"JE Darnell","year":"2002","unstructured":"Darnell, J. E. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer 2, 740\u2013749 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"58795_CR103","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller, J. H. Targeting transcription factors in cancer \u2014 from undruggable to reality. Nat. Rev. Cancer 19, 611\u2013624 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"58795_CR104","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.trecan.2017.10.004","volume":"3","author":"LN Heppler","year":"2017","unstructured":"Heppler, L. N. & Frank, D. A. Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors. Trends Cancer 3, 816\u2013827 (2017).","journal-title":"Trends Cancer"},{"key":"58795_CR105","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.trecan.2015.07.001","volume":"1","author":"AS Bhagwat","year":"2015","unstructured":"Bhagwat, A. S. & Vakoc, C. R. Targeting Transcription Factors in Cancer. Trends Cancer 1, 53\u201365 (2015).","journal-title":"Trends Cancer"},{"key":"58795_CR106","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/1541-7786.MCR-16-0221","volume":"15","author":"EJ Faivre","year":"2017","unstructured":"Faivre, E. J. et al. Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075. Mol. Cancer Res. 15, 35\u201344 (2017).","journal-title":"Mol. Cancer Res."},{"key":"58795_CR107","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1158\/0008-5472.CAN-16-1793","volume":"77","author":"MH Bui","year":"2017","unstructured":"Bui, M. H. et al. Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies. Cancer Res. 77, 2976\u20132989 (2017).","journal-title":"Cancer Res."},{"key":"58795_CR108","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1158\/1078-0432.CCR-19-0578","volume":"25","author":"SA Piha-Paul","year":"2019","unstructured":"Piha-Paul, S. A. et al. First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed\/Refractory Solid Tumors. Clin. Cancer Res. 25, 6309\u20136319 (2019).","journal-title":"Clin. Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58795-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T20:04:54Z","timestamp":1744920294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58795-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58795"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58795-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3675"}}